The CDK9 PROTAC THAL-SNS-032 depleted cellular levels of CDK9 (and partly also other CDKs) in hESCs already at 1 μM concentration (Fig. 6b), presumably due to higher expression of CRBN ubiquitin ligase in hESCs compared to A375 melanoma. The gene discussed is CDK9; the disease is melanoma.